RECCE technology now shows performance against cancer

RECCE technology now shows performance against cancer

Australian early-stage pharmaceutical company, Recce Ltd (ASX: RCE) today announced that RECCE ® antibiotic has demonstrated effective anticancer activities against 7 human cell lines of cancers: Leukaemia, stomach, intestine, breast, prostate, …

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.